Lineage Cell Therapeutics
LCTX
#8223
Rank
ยฃ0.12 B
Marketcap
ยฃ0.65
Share price
1.22%
Change (1 day)
-37.02%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2024 (TTM): -ยฃ20.41 M

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings (TTM) are -ยฃ19.59 M. In 2023 the company made an earning of -ยฃ18.93 M a decrease over its 2022 earnings that were of -ยฃ17.24 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ20.41 M7.81%
2023 -ยฃ18.93 M9.83%
2022 -ยฃ17.24 M-54.24%
2021 -ยฃ37.66 M86.07%
2020 -ยฃ20.24 M-31.97%
2019 -ยฃ29.75 M-5.42%
2018 -ยฃ31.46 M1.1%
2017 -ยฃ31.11 M-31.06%
2016 -ยฃ45.13 M-10.38%
2015 -ยฃ50.36 M29.69%
2014 -ยฃ38.83 M31.68%
2013 -ยฃ29.49 M
2011 -ยฃ14.31 M89.78%
2010 -ยฃ7.54 M206.06%
2009 -ยฃ2.47 M-0.58%
2008 -ยฃ2.48 M164.89%
2007 -ยฃ0.94 M-30.22%
2006 -ยฃ1.35 M
2002 -ยฃ1.56 M-41.04%
2001 -ยฃ2.65 M-32.04%
2000 -ยฃ3.89 M-11.85%
1999 -ยฃ4.41 M
1997 -ยฃ2.84 M12.12%
1996 -ยฃ2.53 M106.25%
1995 -ยฃ1.23 M-11.11%
1994 -ยฃ1.38 M50%
1993 -ยฃ0.92 M20%
1992 -ยฃ0.77 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-ยฃ95.74 M 388.83%๐Ÿ‡บ๐Ÿ‡ธ USA